nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Terazosin—hypertension	0.13	0.346	CrCtD
Alfuzosin—Prazosin—hypertension	0.13	0.346	CrCtD
Alfuzosin—Doxazosin—hypertension	0.116	0.308	CrCtD
Alfuzosin—ADRA1A—hypertension	0.0976	1	CbGaD
Alfuzosin—Terazosin—Prazosin—hypertension	0.0434	0.186	CrCrCtD
Alfuzosin—Prazosin—Terazosin—hypertension	0.0434	0.186	CrCrCtD
Alfuzosin—Terazosin—Doxazosin—hypertension	0.0387	0.166	CrCrCtD
Alfuzosin—Prazosin—Doxazosin—hypertension	0.0387	0.166	CrCrCtD
Alfuzosin—Doxazosin—Prazosin—hypertension	0.0345	0.148	CrCrCtD
Alfuzosin—Doxazosin—Terazosin—hypertension	0.0345	0.148	CrCrCtD
Alfuzosin—ADRA1D—Terazosin—hypertension	0.011	0.0579	CbGbCtD
Alfuzosin—ADRA1D—Fenoldopam—hypertension	0.00997	0.0524	CbGbCtD
Alfuzosin—KCNH2—Terazosin—hypertension	0.00934	0.0491	CbGbCtD
Alfuzosin—ADRA1D—Doxazosin—hypertension	0.0092	0.0484	CbGbCtD
Alfuzosin—ADRA1B—Terazosin—hypertension	0.00803	0.0422	CbGbCtD
Alfuzosin—KCNH2—Doxazosin—hypertension	0.00779	0.041	CbGbCtD
Alfuzosin—ADRA1D—Prazosin—hypertension	0.00756	0.0397	CbGbCtD
Alfuzosin—ADRA1B—Fenoldopam—hypertension	0.00726	0.0381	CbGbCtD
Alfuzosin—KCNH2—Bepridil—hypertension	0.00671	0.0353	CbGbCtD
Alfuzosin—ADRA1B—Doxazosin—hypertension	0.0067	0.0352	CbGbCtD
Alfuzosin—ADRA1D—Carvedilol—hypertension	0.00652	0.0343	CbGbCtD
Alfuzosin—ADRA1D—Nicardipine—hypertension	0.00652	0.0343	CbGbCtD
Alfuzosin—KCNH2—Prazosin—hypertension	0.0064	0.0336	CbGbCtD
Alfuzosin—ADRA1A—Terazosin—hypertension	0.00633	0.0333	CbGbCtD
Alfuzosin—ADRA1A—Fenoldopam—hypertension	0.00573	0.0301	CbGbCtD
Alfuzosin—ADRA1D—Clonidine—hypertension	0.00573	0.0301	CbGbCtD
Alfuzosin—KCNH2—Carvedilol—hypertension	0.00552	0.029	CbGbCtD
Alfuzosin—ADRA1B—Prazosin—hypertension	0.0055	0.0289	CbGbCtD
Alfuzosin—ADRA1A—Doxazosin—hypertension	0.00528	0.0278	CbGbCtD
Alfuzosin—ADRA1B—Carvedilol—hypertension	0.00475	0.025	CbGbCtD
Alfuzosin—ADRA1B—Nicardipine—hypertension	0.00475	0.025	CbGbCtD
Alfuzosin—ADRA1A—Prazosin—hypertension	0.00434	0.0228	CbGbCtD
Alfuzosin—ADRA1B—Clonidine—hypertension	0.00417	0.0219	CbGbCtD
Alfuzosin—ADRA1B—vas deferens—hypertension	0.00377	0.562	CbGeAlD
Alfuzosin—ADRA1A—Carvedilol—hypertension	0.00375	0.0197	CbGbCtD
Alfuzosin—ADRA1A—Nicardipine—hypertension	0.00375	0.0197	CbGbCtD
Alfuzosin—KCNH2—Verapamil—hypertension	0.00349	0.0183	CbGbCtD
Alfuzosin—ADRA1A—Clonidine—hypertension	0.00329	0.0173	CbGbCtD
Alfuzosin—CYP3A4—Guanethidine—hypertension	0.00231	0.0121	CbGbCtD
Alfuzosin—CYP3A4—Hydralazine—hypertension	0.00175	0.00918	CbGbCtD
Alfuzosin—CYP3A4—Guanfacine—hypertension	0.00149	0.00781	CbGbCtD
Alfuzosin—CYP3A4—Isradipine—hypertension	0.00132	0.00696	CbGbCtD
Alfuzosin—CYP3A4—Indapamide—hypertension	0.00117	0.00613	CbGbCtD
Alfuzosin—CYP3A4—Nisoldipine—hypertension	0.00117	0.00613	CbGbCtD
Alfuzosin—CYP3A4—Diltiazem—hypertension	0.00113	0.00592	CbGbCtD
Alfuzosin—CYP3A4—Eplerenone—hypertension	0.00113	0.00592	CbGbCtD
Alfuzosin—CYP3A4—Enalapril—hypertension	0.001	0.00527	CbGbCtD
Alfuzosin—CYP3A4—Irbesartan—hypertension	0.000918	0.00482	CbGbCtD
Alfuzosin—CYP3A4—Amlodipine—hypertension	0.0009	0.00473	CbGbCtD
Alfuzosin—CYP3A4—Felodipine—hypertension	0.000868	0.00456	CbGbCtD
Alfuzosin—CYP3A4—Nifedipine—hypertension	0.000839	0.00441	CbGbCtD
Alfuzosin—CYP3A4—Carvedilol—hypertension	0.000826	0.00434	CbGbCtD
Alfuzosin—CYP3A4—Nicardipine—hypertension	0.000826	0.00434	CbGbCtD
Alfuzosin—CYP3A4—Propranolol—hypertension	0.00076	0.004	CbGbCtD
Alfuzosin—CYP3A4—Clonidine—hypertension	0.000725	0.00381	CbGbCtD
Alfuzosin—CYP3A4—Atorvastatin—hypertension	0.000647	0.0034	CbGbCtD
Alfuzosin—CYP3A4—Losartan—hypertension	0.000591	0.00311	CbGbCtD
Alfuzosin—CYP3A4—Verapamil—hypertension	0.000522	0.00274	CbGbCtD
Alfuzosin—CYP3A4—urine—hypertension	0.000315	0.047	CbGeAlD
Alfuzosin—Prazosin—ADRA2B—hypertension	0.00026	0.226	CrCbGaD
Alfuzosin—Terazosin—ADRA1A—hypertension	0.000235	0.204	CrCbGaD
Alfuzosin—ADRA1B—kidney—hypertension	0.000222	0.0331	CbGeAlD
Alfuzosin—KCNH2—cardiac ventricle—hypertension	0.000199	0.0296	CbGeAlD
Alfuzosin—KCNH2—myocardium—hypertension	0.000187	0.0278	CbGeAlD
Alfuzosin—Doxazosin—ADRA1A—hypertension	0.000175	0.152	CrCbGaD
Alfuzosin—Prazosin—ADRA1A—hypertension	0.000161	0.14	CrCbGaD
Alfuzosin—ADRA1A—brainstem—hypertension	0.000156	0.0233	CbGeAlD
Alfuzosin—ADRA1D—endocrine gland—hypertension	0.000152	0.0227	CbGeAlD
Alfuzosin—ADRA1B—central nervous system—hypertension	0.00014	0.0209	CbGeAlD
Alfuzosin—ADRA1D—central nervous system—hypertension	0.000137	0.0204	CbGeAlD
Alfuzosin—ADRA1A—heart—hypertension	0.000135	0.0201	CbGeAlD
Alfuzosin—KCNH2—heart—hypertension	0.00013	0.0194	CbGeAlD
Alfuzosin—ADRA1A—cardiovascular system—hypertension	0.000127	0.019	CbGeAlD
Alfuzosin—Doxazosin—ADRA2A—hypertension	0.000124	0.107	CrCbGaD
Alfuzosin—KCNH2—cardiovascular system—hypertension	0.000123	0.0183	CbGeAlD
Alfuzosin—Prazosin—ADRA2A—hypertension	0.000114	0.099	CrCbGaD
Alfuzosin—KCNH2—cardiac atrium—hypertension	0.000112	0.0166	CbGeAlD
Alfuzosin—KCNH2—medulla oblongata—hypertension	0.000105	0.0157	CbGeAlD
Alfuzosin—ADRA1A—adrenal gland—hypertension	0.000101	0.015	CbGeAlD
Alfuzosin—KCNH2—adrenal gland—hypertension	9.74e-05	0.0145	CbGeAlD
Alfuzosin—ADRA1A—endocrine gland—hypertension	8.74e-05	0.013	CbGeAlD
Alfuzosin—KCNH2—endocrine gland—hypertension	8.44e-05	0.0126	CbGeAlD
Alfuzosin—Prazosin—CYP1A1—hypertension	8.22e-05	0.0713	CrCbGaD
Alfuzosin—ADRA1A—central nervous system—hypertension	7.88e-05	0.0117	CbGeAlD
Alfuzosin—KCNH2—central nervous system—hypertension	7.61e-05	0.0113	CbGeAlD
Alfuzosin—CYP3A4—kidney—hypertension	7.46e-05	0.0111	CbGeAlD
Alfuzosin—CYP3A4—endocrine gland—hypertension	5.23e-05	0.00779	CbGeAlD
Alfuzosin—CYP3A4—central nervous system—hypertension	4.71e-05	0.00702	CbGeAlD
Alfuzosin—Gastrointestinal pain—Hydrochlorothiazide—hypertension	1.03e-05	0.000159	CcSEcCtD
Alfuzosin—Vomiting—Fosinopril—hypertension	1.03e-05	0.000158	CcSEcCtD
Alfuzosin—Malaise—Lisinopril—hypertension	1.03e-05	0.000158	CcSEcCtD
Alfuzosin—Nausea—Propranolol—hypertension	1.02e-05	0.000158	CcSEcCtD
Alfuzosin—Oedema—Ramipril—hypertension	1.02e-05	0.000158	CcSEcCtD
Alfuzosin—Headache—Doxazosin—hypertension	1.02e-05	0.000158	CcSEcCtD
Alfuzosin—Vertigo—Lisinopril—hypertension	1.02e-05	0.000158	CcSEcCtD
Alfuzosin—Dry mouth—Timolol—hypertension	1.02e-05	0.000158	CcSEcCtD
Alfuzosin—Pain—Losartan—hypertension	1.02e-05	0.000158	CcSEcCtD
Alfuzosin—Constipation—Losartan—hypertension	1.02e-05	0.000158	CcSEcCtD
Alfuzosin—Syncope—Lisinopril—hypertension	1.02e-05	0.000157	CcSEcCtD
Alfuzosin—Vomiting—Eplerenone—hypertension	1.02e-05	0.000157	CcSEcCtD
Alfuzosin—Feeling abnormal—Furosemide—hypertension	1.02e-05	0.000157	CcSEcCtD
Alfuzosin—Rash—Fosinopril—hypertension	1.02e-05	0.000157	CcSEcCtD
Alfuzosin—Dermatitis—Fosinopril—hypertension	1.02e-05	0.000157	CcSEcCtD
Alfuzosin—Vomiting—Nifedipine—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Furosemide—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Rash—Eplerenone—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Urticaria—Perindopril—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Headache—Fosinopril—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Dermatitis—Eplerenone—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Diarrhoea—Valsartan—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Asthenia—Clonidine—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Feeling abnormal—Betaxolol—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Vomiting—Verapamil—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Urticaria—Irbesartan—hypertension	1.01e-05	0.000156	CcSEcCtD
Alfuzosin—Shock—Ramipril—hypertension	1.01e-05	0.000155	CcSEcCtD
Alfuzosin—Abdominal pain—Perindopril—hypertension	1.01e-05	0.000155	CcSEcCtD
Alfuzosin—Palpitations—Lisinopril—hypertension	1.01e-05	0.000155	CcSEcCtD
Alfuzosin—Diarrhoea—Olmesartan—hypertension	1e-05	0.000155	CcSEcCtD
Alfuzosin—Headache—Eplerenone—hypertension	1e-05	0.000155	CcSEcCtD
Alfuzosin—Rash—Nifedipine—hypertension	1e-05	0.000155	CcSEcCtD
Alfuzosin—Nervous system disorder—Ramipril—hypertension	1e-05	0.000155	CcSEcCtD
Alfuzosin—Dermatitis—Nifedipine—hypertension	1e-05	0.000155	CcSEcCtD
Alfuzosin—Abdominal pain—Irbesartan—hypertension	1e-05	0.000155	CcSEcCtD
Alfuzosin—Thrombocytopenia—Ramipril—hypertension	1e-05	0.000155	CcSEcCtD
Alfuzosin—Oedema—Timolol—hypertension	1e-05	0.000154	CcSEcCtD
Alfuzosin—Loss of consciousness—Lisinopril—hypertension	1e-05	0.000154	CcSEcCtD
Alfuzosin—Rash—Verapamil—hypertension	1e-05	0.000154	CcSEcCtD
Alfuzosin—Urticaria—Hydrochlorothiazide—hypertension	9.99e-06	0.000154	CcSEcCtD
Alfuzosin—Tachycardia—Ramipril—hypertension	9.99e-06	0.000154	CcSEcCtD
Alfuzosin—Dermatitis—Verapamil—hypertension	9.99e-06	0.000154	CcSEcCtD
Alfuzosin—Headache—Nifedipine—hypertension	9.97e-06	0.000154	CcSEcCtD
Alfuzosin—Pruritus—Clonidine—hypertension	9.95e-06	0.000154	CcSEcCtD
Alfuzosin—Abdominal pain—Hydrochlorothiazide—hypertension	9.94e-06	0.000154	CcSEcCtD
Alfuzosin—Skin disorder—Ramipril—hypertension	9.94e-06	0.000153	CcSEcCtD
Alfuzosin—Infection—Timolol—hypertension	9.94e-06	0.000153	CcSEcCtD
Alfuzosin—Headache—Verapamil—hypertension	9.93e-06	0.000153	CcSEcCtD
Alfuzosin—Nausea—Diltiazem—hypertension	9.91e-06	0.000153	CcSEcCtD
Alfuzosin—Nausea—Indapamide—hypertension	9.91e-06	0.000153	CcSEcCtD
Alfuzosin—Hyperhidrosis—Ramipril—hypertension	9.89e-06	0.000153	CcSEcCtD
Alfuzosin—Asthenia—Trandolapril—hypertension	9.84e-06	0.000152	CcSEcCtD
Alfuzosin—Shock—Timolol—hypertension	9.84e-06	0.000152	CcSEcCtD
Alfuzosin—Feeling abnormal—Losartan—hypertension	9.84e-06	0.000152	CcSEcCtD
Alfuzosin—Urticaria—Furosemide—hypertension	9.83e-06	0.000152	CcSEcCtD
Alfuzosin—Nervous system disorder—Timolol—hypertension	9.81e-06	0.000152	CcSEcCtD
Alfuzosin—Nausea—Carvedilol—hypertension	9.81e-06	0.000151	CcSEcCtD
Alfuzosin—Asthenia—Enalapril—hypertension	9.81e-06	0.000151	CcSEcCtD
Alfuzosin—Abdominal pain—Furosemide—hypertension	9.78e-06	0.000151	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Losartan—hypertension	9.76e-06	0.000151	CcSEcCtD
Alfuzosin—Dizziness—Valsartan—hypertension	9.76e-06	0.000151	CcSEcCtD
Alfuzosin—Urticaria—Betaxolol—hypertension	9.73e-06	0.00015	CcSEcCtD
Alfuzosin—Skin disorder—Timolol—hypertension	9.72e-06	0.00015	CcSEcCtD
Alfuzosin—Dizziness—Olmesartan—hypertension	9.71e-06	0.00015	CcSEcCtD
Alfuzosin—Pruritus—Trandolapril—hypertension	9.71e-06	0.00015	CcSEcCtD
Alfuzosin—Nausea—Doxazosin—hypertension	9.7e-06	0.00015	CcSEcCtD
Alfuzosin—Chest pain—Lisinopril—hypertension	9.68e-06	0.000149	CcSEcCtD
Alfuzosin—Arthralgia—Lisinopril—hypertension	9.68e-06	0.000149	CcSEcCtD
Alfuzosin—Hyperhidrosis—Timolol—hypertension	9.67e-06	0.000149	CcSEcCtD
Alfuzosin—Asthenia—Telmisartan—hypertension	9.67e-06	0.000149	CcSEcCtD
Alfuzosin—Pruritus—Enalapril—hypertension	9.67e-06	0.000149	CcSEcCtD
Alfuzosin—Diarrhoea—Clonidine—hypertension	9.63e-06	0.000149	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	9.62e-06	0.000148	CcSEcCtD
Alfuzosin—Nausea—Fosinopril—hypertension	9.59e-06	0.000148	CcSEcCtD
Alfuzosin—Discomfort—Lisinopril—hypertension	9.57e-06	0.000148	CcSEcCtD
Alfuzosin—Hypotension—Ramipril—hypertension	9.56e-06	0.000148	CcSEcCtD
Alfuzosin—Pruritus—Telmisartan—hypertension	9.54e-06	0.000147	CcSEcCtD
Alfuzosin—Nausea—Eplerenone—hypertension	9.53e-06	0.000147	CcSEcCtD
Alfuzosin—Urticaria—Losartan—hypertension	9.48e-06	0.000146	CcSEcCtD
Alfuzosin—Dry mouth—Lisinopril—hypertension	9.47e-06	0.000146	CcSEcCtD
Alfuzosin—Nausea—Nifedipine—hypertension	9.46e-06	0.000146	CcSEcCtD
Alfuzosin—Abdominal pain—Losartan—hypertension	9.44e-06	0.000146	CcSEcCtD
Alfuzosin—Nausea—Verapamil—hypertension	9.42e-06	0.000145	CcSEcCtD
Alfuzosin—Asthenia—Captopril—hypertension	9.4e-06	0.000145	CcSEcCtD
Alfuzosin—Diarrhoea—Trandolapril—hypertension	9.39e-06	0.000145	CcSEcCtD
Alfuzosin—Vomiting—Valsartan—hypertension	9.38e-06	0.000145	CcSEcCtD
Alfuzosin—Diarrhoea—Enalapril—hypertension	9.35e-06	0.000144	CcSEcCtD
Alfuzosin—Hypotension—Timolol—hypertension	9.35e-06	0.000144	CcSEcCtD
Alfuzosin—Vomiting—Olmesartan—hypertension	9.34e-06	0.000144	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Ramipril—hypertension	9.33e-06	0.000144	CcSEcCtD
Alfuzosin—Rash—Valsartan—hypertension	9.31e-06	0.000144	CcSEcCtD
Alfuzosin—Dizziness—Clonidine—hypertension	9.3e-06	0.000144	CcSEcCtD
Alfuzosin—Dermatitis—Valsartan—hypertension	9.3e-06	0.000144	CcSEcCtD
Alfuzosin—Oedema—Lisinopril—hypertension	9.28e-06	0.000143	CcSEcCtD
Alfuzosin—Pruritus—Captopril—hypertension	9.27e-06	0.000143	CcSEcCtD
Alfuzosin—Rash—Olmesartan—hypertension	9.26e-06	0.000143	CcSEcCtD
Alfuzosin—Dermatitis—Olmesartan—hypertension	9.25e-06	0.000143	CcSEcCtD
Alfuzosin—Headache—Valsartan—hypertension	9.25e-06	0.000143	CcSEcCtD
Alfuzosin—Diarrhoea—Telmisartan—hypertension	9.22e-06	0.000142	CcSEcCtD
Alfuzosin—Infection—Lisinopril—hypertension	9.22e-06	0.000142	CcSEcCtD
Alfuzosin—Headache—Olmesartan—hypertension	9.2e-06	0.000142	CcSEcCtD
Alfuzosin—Shock—Lisinopril—hypertension	9.13e-06	0.000141	CcSEcCtD
Alfuzosin—Asthenia—Perindopril—hypertension	9.13e-06	0.000141	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Timolol—hypertension	9.12e-06	0.000141	CcSEcCtD
Alfuzosin—Asthenia—Irbesartan—hypertension	9.1e-06	0.000141	CcSEcCtD
Alfuzosin—Somnolence—Ramipril—hypertension	9.1e-06	0.00014	CcSEcCtD
Alfuzosin—Thrombocytopenia—Lisinopril—hypertension	9.09e-06	0.00014	CcSEcCtD
Alfuzosin—Dizziness—Trandolapril—hypertension	9.07e-06	0.00014	CcSEcCtD
Alfuzosin—Tachycardia—Lisinopril—hypertension	9.06e-06	0.00014	CcSEcCtD
Alfuzosin—Dizziness—Enalapril—hypertension	9.04e-06	0.00014	CcSEcCtD
Alfuzosin—Asthenia—Hydrochlorothiazide—hypertension	9.03e-06	0.000139	CcSEcCtD
Alfuzosin—Skin disorder—Lisinopril—hypertension	9.02e-06	0.000139	CcSEcCtD
Alfuzosin—Dyspepsia—Ramipril—hypertension	9.01e-06	0.000139	CcSEcCtD
Alfuzosin—Pruritus—Perindopril—hypertension	9e-06	0.000139	CcSEcCtD
Alfuzosin—Pruritus—Irbesartan—hypertension	8.97e-06	0.000139	CcSEcCtD
Alfuzosin—Hyperhidrosis—Lisinopril—hypertension	8.97e-06	0.000139	CcSEcCtD
Alfuzosin—Diarrhoea—Captopril—hypertension	8.97e-06	0.000138	CcSEcCtD
Alfuzosin—Vomiting—Clonidine—hypertension	8.95e-06	0.000138	CcSEcCtD
Alfuzosin—Dizziness—Telmisartan—hypertension	8.91e-06	0.000138	CcSEcCtD
Alfuzosin—Pruritus—Hydrochlorothiazide—hypertension	8.9e-06	0.000137	CcSEcCtD
Alfuzosin—Somnolence—Timolol—hypertension	8.9e-06	0.000137	CcSEcCtD
Alfuzosin—Asthenia—Furosemide—hypertension	8.88e-06	0.000137	CcSEcCtD
Alfuzosin—Rash—Clonidine—hypertension	8.87e-06	0.000137	CcSEcCtD
Alfuzosin—Dermatitis—Clonidine—hypertension	8.86e-06	0.000137	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Ramipril—hypertension	8.84e-06	0.000136	CcSEcCtD
Alfuzosin—Fatigue—Ramipril—hypertension	8.82e-06	0.000136	CcSEcCtD
Alfuzosin—Headache—Clonidine—hypertension	8.81e-06	0.000136	CcSEcCtD
Alfuzosin—Dyspepsia—Timolol—hypertension	8.81e-06	0.000136	CcSEcCtD
Alfuzosin—Asthenia—Betaxolol—hypertension	8.79e-06	0.000136	CcSEcCtD
Alfuzosin—Nausea—Valsartan—hypertension	8.77e-06	0.000135	CcSEcCtD
Alfuzosin—Pruritus—Furosemide—hypertension	8.75e-06	0.000135	CcSEcCtD
Alfuzosin—Constipation—Ramipril—hypertension	8.75e-06	0.000135	CcSEcCtD
Alfuzosin—Nausea—Olmesartan—hypertension	8.72e-06	0.000135	CcSEcCtD
Alfuzosin—Vomiting—Trandolapril—hypertension	8.72e-06	0.000135	CcSEcCtD
Alfuzosin—Diarrhoea—Perindopril—hypertension	8.71e-06	0.000134	CcSEcCtD
Alfuzosin—Vomiting—Enalapril—hypertension	8.69e-06	0.000134	CcSEcCtD
Alfuzosin—Diarrhoea—Irbesartan—hypertension	8.68e-06	0.000134	CcSEcCtD
Alfuzosin—Hypotension—Lisinopril—hypertension	8.67e-06	0.000134	CcSEcCtD
Alfuzosin—Dizziness—Captopril—hypertension	8.67e-06	0.000134	CcSEcCtD
Alfuzosin—Pruritus—Betaxolol—hypertension	8.67e-06	0.000134	CcSEcCtD
Alfuzosin—Rash—Trandolapril—hypertension	8.65e-06	0.000134	CcSEcCtD
Alfuzosin—Dermatitis—Trandolapril—hypertension	8.64e-06	0.000133	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Timolol—hypertension	8.64e-06	0.000133	CcSEcCtD
Alfuzosin—Fatigue—Timolol—hypertension	8.63e-06	0.000133	CcSEcCtD
Alfuzosin—Rash—Enalapril—hypertension	8.62e-06	0.000133	CcSEcCtD
Alfuzosin—Dermatitis—Enalapril—hypertension	8.61e-06	0.000133	CcSEcCtD
Alfuzosin—Diarrhoea—Hydrochlorothiazide—hypertension	8.61e-06	0.000133	CcSEcCtD
Alfuzosin—Headache—Trandolapril—hypertension	8.6e-06	0.000133	CcSEcCtD
Alfuzosin—Vomiting—Telmisartan—hypertension	8.57e-06	0.000132	CcSEcCtD
Alfuzosin—Asthenia—Losartan—hypertension	8.56e-06	0.000132	CcSEcCtD
Alfuzosin—Headache—Enalapril—hypertension	8.56e-06	0.000132	CcSEcCtD
Alfuzosin—Pain—Timolol—hypertension	8.56e-06	0.000132	CcSEcCtD
Alfuzosin—Rash—Telmisartan—hypertension	8.5e-06	0.000131	CcSEcCtD
Alfuzosin—Dermatitis—Telmisartan—hypertension	8.49e-06	0.000131	CcSEcCtD
Alfuzosin—Diarrhoea—Furosemide—hypertension	8.46e-06	0.000131	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Lisinopril—hypertension	8.46e-06	0.000131	CcSEcCtD
Alfuzosin—Pruritus—Losartan—hypertension	8.45e-06	0.00013	CcSEcCtD
Alfuzosin—Headache—Telmisartan—hypertension	8.44e-06	0.00013	CcSEcCtD
Alfuzosin—Feeling abnormal—Ramipril—hypertension	8.43e-06	0.00013	CcSEcCtD
Alfuzosin—Dizziness—Perindopril—hypertension	8.42e-06	0.00013	CcSEcCtD
Alfuzosin—Dizziness—Irbesartan—hypertension	8.39e-06	0.000129	CcSEcCtD
Alfuzosin—Diarrhoea—Betaxolol—hypertension	8.38e-06	0.000129	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Ramipril—hypertension	8.37e-06	0.000129	CcSEcCtD
Alfuzosin—Nausea—Clonidine—hypertension	8.36e-06	0.000129	CcSEcCtD
Alfuzosin—Vomiting—Captopril—hypertension	8.33e-06	0.000129	CcSEcCtD
Alfuzosin—Dizziness—Hydrochlorothiazide—hypertension	8.32e-06	0.000128	CcSEcCtD
Alfuzosin—Rash—Captopril—hypertension	8.26e-06	0.000128	CcSEcCtD
Alfuzosin—Dermatitis—Captopril—hypertension	8.26e-06	0.000127	CcSEcCtD
Alfuzosin—Somnolence—Lisinopril—hypertension	8.25e-06	0.000127	CcSEcCtD
Alfuzosin—Feeling abnormal—Timolol—hypertension	8.25e-06	0.000127	CcSEcCtD
Alfuzosin—Headache—Captopril—hypertension	8.21e-06	0.000127	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Timolol—hypertension	8.18e-06	0.000126	CcSEcCtD
Alfuzosin—Dizziness—Furosemide—hypertension	8.18e-06	0.000126	CcSEcCtD
Alfuzosin—Dyspepsia—Lisinopril—hypertension	8.17e-06	0.000126	CcSEcCtD
Alfuzosin—Diarrhoea—Losartan—hypertension	8.17e-06	0.000126	CcSEcCtD
Alfuzosin—Nausea—Trandolapril—hypertension	8.15e-06	0.000126	CcSEcCtD
Alfuzosin—Urticaria—Ramipril—hypertension	8.13e-06	0.000126	CcSEcCtD
Alfuzosin—Nausea—Enalapril—hypertension	8.12e-06	0.000125	CcSEcCtD
Alfuzosin—Dizziness—Betaxolol—hypertension	8.1e-06	0.000125	CcSEcCtD
Alfuzosin—Vomiting—Perindopril—hypertension	8.09e-06	0.000125	CcSEcCtD
Alfuzosin—Abdominal pain—Ramipril—hypertension	8.09e-06	0.000125	CcSEcCtD
Alfuzosin—Vomiting—Irbesartan—hypertension	8.06e-06	0.000125	CcSEcCtD
Alfuzosin—Rash—Perindopril—hypertension	8.02e-06	0.000124	CcSEcCtD
Alfuzosin—Dermatitis—Perindopril—hypertension	8.02e-06	0.000124	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Lisinopril—hypertension	8.01e-06	0.000124	CcSEcCtD
Alfuzosin—Nausea—Telmisartan—hypertension	8.01e-06	0.000124	CcSEcCtD
Alfuzosin—Fatigue—Lisinopril—hypertension	8e-06	0.000124	CcSEcCtD
Alfuzosin—Vomiting—Hydrochlorothiazide—hypertension	8e-06	0.000123	CcSEcCtD
Alfuzosin—Rash—Irbesartan—hypertension	8e-06	0.000123	CcSEcCtD
Alfuzosin—Dermatitis—Irbesartan—hypertension	7.99e-06	0.000123	CcSEcCtD
Alfuzosin—Headache—Perindopril—hypertension	7.97e-06	0.000123	CcSEcCtD
Alfuzosin—Urticaria—Timolol—hypertension	7.95e-06	0.000123	CcSEcCtD
Alfuzosin—Headache—Irbesartan—hypertension	7.95e-06	0.000123	CcSEcCtD
Alfuzosin—Constipation—Lisinopril—hypertension	7.94e-06	0.000123	CcSEcCtD
Alfuzosin—Pain—Lisinopril—hypertension	7.94e-06	0.000123	CcSEcCtD
Alfuzosin—Rash—Hydrochlorothiazide—hypertension	7.93e-06	0.000122	CcSEcCtD
Alfuzosin—Dermatitis—Hydrochlorothiazide—hypertension	7.92e-06	0.000122	CcSEcCtD
Alfuzosin—Abdominal pain—Timolol—hypertension	7.91e-06	0.000122	CcSEcCtD
Alfuzosin—Dizziness—Losartan—hypertension	7.89e-06	0.000122	CcSEcCtD
Alfuzosin—Headache—Hydrochlorothiazide—hypertension	7.88e-06	0.000122	CcSEcCtD
Alfuzosin—Vomiting—Furosemide—hypertension	7.87e-06	0.000121	CcSEcCtD
Alfuzosin—Rash—Furosemide—hypertension	7.8e-06	0.00012	CcSEcCtD
Alfuzosin—Dermatitis—Furosemide—hypertension	7.79e-06	0.00012	CcSEcCtD
Alfuzosin—Vomiting—Betaxolol—hypertension	7.79e-06	0.00012	CcSEcCtD
Alfuzosin—Nausea—Captopril—hypertension	7.79e-06	0.00012	CcSEcCtD
Alfuzosin—Headache—Furosemide—hypertension	7.75e-06	0.00012	CcSEcCtD
Alfuzosin—Rash—Betaxolol—hypertension	7.72e-06	0.000119	CcSEcCtD
Alfuzosin—Dermatitis—Betaxolol—hypertension	7.72e-06	0.000119	CcSEcCtD
Alfuzosin—Headache—Betaxolol—hypertension	7.67e-06	0.000118	CcSEcCtD
Alfuzosin—Feeling abnormal—Lisinopril—hypertension	7.65e-06	0.000118	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Lisinopril—hypertension	7.59e-06	0.000117	CcSEcCtD
Alfuzosin—Vomiting—Losartan—hypertension	7.59e-06	0.000117	CcSEcCtD
Alfuzosin—Nausea—Perindopril—hypertension	7.56e-06	0.000117	CcSEcCtD
Alfuzosin—Nausea—Irbesartan—hypertension	7.53e-06	0.000116	CcSEcCtD
Alfuzosin—Rash—Losartan—hypertension	7.53e-06	0.000116	CcSEcCtD
Alfuzosin—Dermatitis—Losartan—hypertension	7.52e-06	0.000116	CcSEcCtD
Alfuzosin—Headache—Losartan—hypertension	7.48e-06	0.000115	CcSEcCtD
Alfuzosin—Nausea—Hydrochlorothiazide—hypertension	7.47e-06	0.000115	CcSEcCtD
Alfuzosin—Urticaria—Lisinopril—hypertension	7.37e-06	0.000114	CcSEcCtD
Alfuzosin—Nausea—Furosemide—hypertension	7.35e-06	0.000113	CcSEcCtD
Alfuzosin—Asthenia—Ramipril—hypertension	7.34e-06	0.000113	CcSEcCtD
Alfuzosin—Abdominal pain—Lisinopril—hypertension	7.34e-06	0.000113	CcSEcCtD
Alfuzosin—Nausea—Betaxolol—hypertension	7.28e-06	0.000112	CcSEcCtD
Alfuzosin—Pruritus—Ramipril—hypertension	7.24e-06	0.000112	CcSEcCtD
Alfuzosin—Asthenia—Timolol—hypertension	7.18e-06	0.000111	CcSEcCtD
Alfuzosin—Nausea—Losartan—hypertension	7.09e-06	0.000109	CcSEcCtD
Alfuzosin—Pruritus—Timolol—hypertension	7.08e-06	0.000109	CcSEcCtD
Alfuzosin—Diarrhoea—Ramipril—hypertension	7e-06	0.000108	CcSEcCtD
Alfuzosin—Diarrhoea—Timolol—hypertension	6.85e-06	0.000106	CcSEcCtD
Alfuzosin—Dizziness—Ramipril—hypertension	6.77e-06	0.000104	CcSEcCtD
Alfuzosin—Asthenia—Lisinopril—hypertension	6.66e-06	0.000103	CcSEcCtD
Alfuzosin—Dizziness—Timolol—hypertension	6.62e-06	0.000102	CcSEcCtD
Alfuzosin—Pruritus—Lisinopril—hypertension	6.57e-06	0.000101	CcSEcCtD
Alfuzosin—Vomiting—Ramipril—hypertension	6.51e-06	0.0001	CcSEcCtD
Alfuzosin—Rash—Ramipril—hypertension	6.45e-06	9.96e-05	CcSEcCtD
Alfuzosin—Dermatitis—Ramipril—hypertension	6.45e-06	9.95e-05	CcSEcCtD
Alfuzosin—Headache—Ramipril—hypertension	6.41e-06	9.9e-05	CcSEcCtD
Alfuzosin—Vomiting—Timolol—hypertension	6.36e-06	9.82e-05	CcSEcCtD
Alfuzosin—Diarrhoea—Lisinopril—hypertension	6.35e-06	9.81e-05	CcSEcCtD
Alfuzosin—Rash—Timolol—hypertension	6.31e-06	9.74e-05	CcSEcCtD
Alfuzosin—Dermatitis—Timolol—hypertension	6.3e-06	9.73e-05	CcSEcCtD
Alfuzosin—Headache—Timolol—hypertension	6.27e-06	9.68e-05	CcSEcCtD
Alfuzosin—Dizziness—Lisinopril—hypertension	6.14e-06	9.48e-05	CcSEcCtD
Alfuzosin—Nausea—Ramipril—hypertension	6.08e-06	9.39e-05	CcSEcCtD
Alfuzosin—Nausea—Timolol—hypertension	5.94e-06	9.18e-05	CcSEcCtD
Alfuzosin—Vomiting—Lisinopril—hypertension	5.9e-06	9.11e-05	CcSEcCtD
Alfuzosin—Rash—Lisinopril—hypertension	5.85e-06	9.04e-05	CcSEcCtD
Alfuzosin—Dermatitis—Lisinopril—hypertension	5.85e-06	9.03e-05	CcSEcCtD
Alfuzosin—Headache—Lisinopril—hypertension	5.82e-06	8.98e-05	CcSEcCtD
Alfuzosin—Nausea—Lisinopril—hypertension	5.51e-06	8.51e-05	CcSEcCtD
Alfuzosin—CYP3A4—Metabolism—UCP3—hypertension	1.4e-06	4.69e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSD11B1—hypertension	1.4e-06	4.69e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCC1—hypertension	1.4e-06	4.69e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CALM1—hypertension	1.39e-06	4.66e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCE—hypertension	1.38e-06	4.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOE—hypertension	1.38e-06	4.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LEP—hypertension	1.38e-06	4.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CAV1—hypertension	1.37e-06	4.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LPL—hypertension	1.37e-06	4.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VAV3—hypertension	1.37e-06	4.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PDGFA—hypertension	1.37e-06	4.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOA1—hypertension	1.37e-06	4.59e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—H2AFX—hypertension	1.36e-06	4.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PDGFRB—hypertension	1.36e-06	4.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RPS6KB1—hypertension	1.36e-06	4.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KDR—hypertension	1.35e-06	4.55e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP11B2—hypertension	1.35e-06	4.55e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALAS1—hypertension	1.35e-06	4.55e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC2A3—hypertension	1.35e-06	4.55e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFBR2—hypertension	1.35e-06	4.53e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADCY5—hypertension	1.34e-06	4.5e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GNB3—hypertension	1.34e-06	4.49e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ADA—hypertension	1.33e-06	4.48e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSD3B1—hypertension	1.33e-06	4.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCG—hypertension	1.33e-06	4.47e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ITGB3—hypertension	1.32e-06	4.44e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCA—hypertension	1.32e-06	4.44e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AVP—hypertension	1.32e-06	4.43e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FADS1—hypertension	1.31e-06	4.41e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AQP1—hypertension	1.31e-06	4.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—YWHAZ—hypertension	1.31e-06	4.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—RHOA—hypertension	1.31e-06	4.39e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—F2—hypertension	1.3e-06	4.38e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKCB—hypertension	1.3e-06	4.38e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FN1—hypertension	1.3e-06	4.38e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GNAS—hypertension	1.3e-06	4.37e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NGF—hypertension	1.3e-06	4.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SPP1—hypertension	1.3e-06	4.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3R1—hypertension	1.29e-06	4.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCL8—hypertension	1.29e-06	4.34e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CA9—hypertension	1.28e-06	4.29e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TBXAS1—hypertension	1.28e-06	4.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH1—hypertension	1.28e-06	4.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOB—hypertension	1.27e-06	4.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTK2—hypertension	1.27e-06	4.26e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCL8—hypertension	1.26e-06	4.24e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCR5—hypertension	1.26e-06	4.24e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCD—hypertension	1.26e-06	4.24e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EDN1—hypertension	1.25e-06	4.21e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALOX15—hypertension	1.24e-06	4.18e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALOX5AP—hypertension	1.24e-06	4.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL5—hypertension	1.24e-06	4.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2A—hypertension	1.23e-06	4.15e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—C3—hypertension	1.23e-06	4.14e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LPL—hypertension	1.22e-06	4.09e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HADHA—hypertension	1.22e-06	4.08e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LHB—hypertension	1.22e-06	4.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—H2AFX—hypertension	1.21e-06	4.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PDGFRB—hypertension	1.21e-06	4.05e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RPS6KB1—hypertension	1.21e-06	4.05e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PDGFB—hypertension	1.2e-06	4.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGFR1—hypertension	1.19e-06	4.01e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADCY5—hypertension	1.19e-06	4e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—POMC—hypertension	1.19e-06	3.99e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPA—hypertension	1.19e-06	3.99e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSD3B2—hypertension	1.19e-06	3.99e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—KCNJ11—hypertension	1.19e-06	3.99e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCG—hypertension	1.18e-06	3.97e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—INS—hypertension	1.18e-06	3.97e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HIF1A—hypertension	1.18e-06	3.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCA—hypertension	1.17e-06	3.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ITGB3—hypertension	1.17e-06	3.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGT—hypertension	1.17e-06	3.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—YWHAZ—hypertension	1.16e-06	3.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL2—hypertension	1.16e-06	3.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NGF—hypertension	1.15e-06	3.87e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SPP1—hypertension	1.15e-06	3.87e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CALM1—hypertension	1.15e-06	3.87e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LEP—hypertension	1.15e-06	3.86e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOE—hypertension	1.15e-06	3.86e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCL8—hypertension	1.15e-06	3.85e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1—hypertension	1.14e-06	3.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT2—hypertension	1.14e-06	3.84e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LRP2—hypertension	1.14e-06	3.83e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2C18—hypertension	1.14e-06	3.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CAV1—hypertension	1.14e-06	3.82e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—EGFR—hypertension	1.14e-06	3.82e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOA1—hypertension	1.13e-06	3.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KDR—hypertension	1.12e-06	3.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCD—hypertension	1.12e-06	3.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCR5—hypertension	1.12e-06	3.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2A—hypertension	1.1e-06	3.68e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSPG2—hypertension	1.1e-06	3.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—C3—hypertension	1.09e-06	3.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SERPINE1—hypertension	1.09e-06	3.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FN1—hypertension	1.08e-06	3.64e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCB—hypertension	1.08e-06	3.64e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—F2—hypertension	1.08e-06	3.64e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PDGFB—hypertension	1.07e-06	3.58e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGFR1—hypertension	1.06e-06	3.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH1—hypertension	1.06e-06	3.56e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALOX5—hypertension	1.06e-06	3.56e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GLP1R—hypertension	1.06e-06	3.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FGF2—hypertension	1.05e-06	3.53e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RHOA—hypertension	1.05e-06	3.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HIF1A—hypertension	1.04e-06	3.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGT—hypertension	1.04e-06	3.5e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3R1—hypertension	1.04e-06	3.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOS3—hypertension	1.04e-06	3.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CALM1—hypertension	1.02e-06	3.44e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOE—hypertension	1.02e-06	3.43e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LEP—hypertension	1.02e-06	3.43e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CAV1—hypertension	1.01e-06	3.39e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOA1—hypertension	1.01e-06	3.39e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KDR—hypertension	9.99e-07	3.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—POMC—hypertension	9.86e-07	3.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—INS—hypertension	9.8e-07	3.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RELA—hypertension	9.75e-07	3.28e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALDH2—hypertension	9.68e-07	3.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL2—hypertension	9.65e-07	3.24e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FN1—hypertension	9.61e-07	3.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—F2—hypertension	9.61e-07	3.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCB—hypertension	9.61e-07	3.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MTOR—hypertension	9.56e-07	3.21e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1—hypertension	9.48e-07	3.19e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT2—hypertension	9.48e-07	3.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—EGFR—hypertension	9.44e-07	3.17e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HBA1—hypertension	9.43e-07	3.17e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH1—hypertension	9.41e-07	3.16e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP11A1—hypertension	9.38e-07	3.15e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC9A1—hypertension	9.21e-07	3.09e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTT1—hypertension	9.21e-07	3.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL8—hypertension	9.19e-07	3.09e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCLC—hypertension	9.1e-07	3.06e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CETP—hypertension	9.1e-07	3.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SERPINE1—hypertension	9.01e-07	3.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—hypertension	8.88e-07	2.98e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—POMC—hypertension	8.76e-07	2.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—hypertension	8.74e-07	2.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGF2—hypertension	8.72e-07	2.93e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP17A1—hypertension	8.72e-07	2.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—INS—hypertension	8.71e-07	2.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RHOA—hypertension	8.69e-07	2.92e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS1—hypertension	8.63e-07	2.9e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ENO1—hypertension	8.63e-07	2.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOS3—hypertension	8.6e-07	2.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3R1—hypertension	8.6e-07	2.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL2—hypertension	8.57e-07	2.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1—hypertension	8.42e-07	2.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT2—hypertension	8.42e-07	2.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—EGFR—hypertension	8.38e-07	2.82e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—hypertension	8.31e-07	2.79e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CTGF—hypertension	8.31e-07	2.79e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CDKN1A—hypertension	8.28e-07	2.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTEN—hypertension	8.26e-07	2.78e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMGCR—hypertension	8.23e-07	2.77e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GOT2—hypertension	8.23e-07	2.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RELA—hypertension	8.09e-07	2.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK8—hypertension	8.08e-07	2.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—hypertension	8.06e-07	2.71e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ADRA2A—hypertension	8.06e-07	2.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SERPINE1—hypertension	8e-07	2.69e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MTOR—hypertension	7.94e-07	2.67e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EP300—hypertension	7.88e-07	2.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGF2—hypertension	7.74e-07	2.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RHOA—hypertension	7.72e-07	2.59e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SRC—hypertension	7.66e-07	2.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3R1—hypertension	7.64e-07	2.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOS3—hypertension	7.64e-07	2.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL8—hypertension	7.63e-07	2.56e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TH—hypertension	7.54e-07	2.53e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CALM2—hypertension	7.52e-07	2.53e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—hypertension	7.46e-07	2.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—hypertension	7.37e-07	2.48e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC2A4—hypertension	7.34e-07	2.47e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCG—hypertension	7.34e-07	2.47e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—hypertension	7.25e-07	2.44e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RELA—hypertension	7.19e-07	2.42e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GOT1—hypertension	7.11e-07	2.39e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MTOR—hypertension	7.05e-07	2.37e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—hypertension	6.9e-07	2.32e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP19A1—hypertension	6.9e-07	2.32e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—STK11—hypertension	6.9e-07	2.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CDKN1A—hypertension	6.87e-07	2.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MYC—hypertension	6.87e-07	2.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTEN—hypertension	6.86e-07	2.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—hypertension	6.85e-07	2.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL8—hypertension	6.77e-07	2.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGFR—hypertension	6.72e-07	2.26e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK8—hypertension	6.71e-07	2.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—hypertension	6.69e-07	2.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—hypertension	6.54e-07	2.2e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EP300—hypertension	6.54e-07	2.2e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—hypertension	6.44e-07	2.16e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—COMT—hypertension	6.41e-07	2.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SRC—hypertension	6.36e-07	2.14e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GNB3—hypertension	6.32e-07	2.12e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARGC1A—hypertension	6.32e-07	2.12e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMOX1—hypertension	6.29e-07	2.12e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAT—hypertension	6.21e-07	2.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—hypertension	6.19e-07	2.08e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GNAS—hypertension	6.16e-07	2.07e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—hypertension	6.13e-07	2.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDKN1A—hypertension	6.11e-07	2.05e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTEN—hypertension	6.09e-07	2.05e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOB—hypertension	6.03e-07	2.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK8—hypertension	5.96e-07	2e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—hypertension	5.94e-07	2e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTM1—hypertension	5.87e-07	1.97e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EP300—hypertension	5.81e-07	1.95e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPL—hypertension	5.76e-07	1.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MYC—hypertension	5.7e-07	1.92e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—hypertension	5.69e-07	1.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SRC—hypertension	5.65e-07	1.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TP53—hypertension	5.64e-07	1.89e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ADCY5—hypertension	5.64e-07	1.89e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX1—hypertension	5.62e-07	1.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGFR—hypertension	5.57e-07	1.87e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PRKCA—hypertension	5.56e-07	1.87e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP1A1—hypertension	5.56e-07	1.87e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—hypertension	5.5e-07	1.85e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CD36—hypertension	5.47e-07	1.84e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTHFR—hypertension	5.18e-07	1.74e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—hypertension	5.16e-07	1.73e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARA—hypertension	5.09e-07	1.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MYC—hypertension	5.06e-07	1.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—hypertension	5.05e-07	1.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGFR—hypertension	4.95e-07	1.66e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AGT—hypertension	4.93e-07	1.66e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CALM1—hypertension	4.84e-07	1.63e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOE—hypertension	4.83e-07	1.62e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAV1—hypertension	4.78e-07	1.61e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA1—hypertension	4.77e-07	1.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—hypertension	4.76e-07	1.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TP53—hypertension	4.68e-07	1.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—hypertension	4.28e-07	1.44e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—hypertension	4.2e-07	1.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TP53—hypertension	4.16e-07	1.4e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—POMC—hypertension	4.15e-07	1.39e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—INS—hypertension	4.12e-07	1.39e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—hypertension	3.95e-07	1.33e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—hypertension	3.81e-07	1.28e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—hypertension	3.78e-07	1.27e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3R1—hypertension	3.62e-07	1.21e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NOS3—hypertension	3.62e-07	1.21e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—hypertension	3.51e-07	1.18e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—hypertension	3.31e-07	1.11e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTEN—hypertension	2.88e-07	9.69e-06	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—EP300—hypertension	2.75e-07	9.24e-06	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—hypertension	1.66e-07	5.58e-06	CbGpPWpGaD
